Apollo Hospitals Enterprise Limited — PPTs, 10-02-2025: Investor Presentation

**Q3 FY25 Investor Presentation Summary:**

1. **Financial Highlights:** In Q3 FY25, Apollo Hospitals reported consolidated revenues of ₹55,269 million, marking a 14% growth year-over-year. EBITDA increased by 24% to ₹7,615 million, with a margin of 13.8%. Profit After Tax (PAT) saw a significant jump of 52% to ₹3,723 million, benefiting from strong operational performance across segments.

2. **Strategic Initiatives and Growth Drivers:** Apollo is focusing on operational efficiencies and service expansions, particularly in digital health and pharmacy distribution. Investments in technology and enhanced service delivery models are expected to drive further revenue growth.

3. **Business Developments:** The company is in the process of integrating Keimed Private Limited to bolster its pharmacy distribution capabilities. This merger aims to enhance its market presence and operational efficiency.

4. **Market Position and Competitive Advantage:** Apollo maintains its status as India's largest integrated healthcare provider, with a robust network of hospitals, clinics, and pharmacies. Its digital health platform enhances customer reach, while strategic expansions in Tier-1 cities should strengthen its competitive edge.

5. **Investor Implications:** Investors should note Apollo's positive outlook, bolstered by revenue growth, increasing margins, and strategic acquisitions. The expected operational efficiencies and expansion plans present potential growth opportunities in a competitive market.